Revansiddha Katte

6PUBLICATIONS
10CO-AUTHORS
Innate immunityMedical molecular engineering of nucleic acids and proteinsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersState crime
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 28, 2026
Structure-Guided Design of Peptide Inhibitors Targeting Class I Viral Fusion Proteins.

Narendra Kumar Gonepudi, Harry Baffour Awuah, Wang Xu

|May 17, 2025
Conformational trajectory of the HIV-1 fusion peptide during CD4-induced envelope opening.

Bhishem Thakur, Revansiddha H Katte, Wang Xu

|Feb 25, 2025
Inter-protomer opening cooperativity of envelope trimers positively correlates with HIV-1 entry stoichiometry.

Revansiddha H Katte, Wang Xu, Yang Han

|Mar 28, 2024
Differentiating Cell Entry Potentials of SARS-CoV-2 Omicron Subvariants on Human Lung Epithelium Cells.

Revansiddha H Katte, Yuanyun Ao, Wang Xu

|Apr 30, 2021
S100P Interacts with p53 while Pentamidine Inhibits This Interaction.

Revansiddha H Katte, Deepu Dowarha, Ruey-Hwang Chou

|Jun 15, 2018
Blocking the interaction between S100A9 protein and RAGE V domain using S100A12 protein.

Revansiddha Katte, Chin Yu

Pageof 1

Frequent Collaborators

2 joint publications

Maolin Lu

2 joint publications

Wang Xu

1 joint publications

Deepu Dowarha

1 joint publications

Ruey-Hwang Chou